Robert Burns

Robert Burns

Direktor/Vorstandsmitglied bei CIRCIO HOLDING ASA
79 Jahre
Health Technology
Commercial Services
Industrial Services

Profil

Dr. Robert F.
Burns is an Independent Director at Circio Holding ASA and a Chairman at Affibody Medical AB. He is on the Board of Directors at Circio Holding ASA. Dr. Burns was previously employed as a President & Chief Executive Officer by Affitech A/S, a Chairman by Haemostatix Ltd., a President & Chief Executive Officer by Celldex Therapeutics, Inc. (Old), a Chief Executive Officer by 4-Antibody AG, a Principal by ABT Corp, a Principal by Applied Biotech, Inc., a Chief Executive Officer by Celldex Therapeutics, Inc., a Principal by Ligand UK Ltd., a Director-Technology Licensing by Ludwig Institute for Cancer Research Ltd., a Principal by Ogs SA, a Principal by Oxford GlycoSciences Plc, and a Principal by Piramed Ltd. He also served on the board at Targovax Oy.
He received his doctorate degree from the University of Birmingham.

Aktive Positionen von Robert Burns

UnternehmenPositionBeginn
CIRCIO HOLDING ASA Direktor/Vorstandsmitglied 01.07.2015
Vorsitzender -

Ehemalige bekannte Positionen von Robert Burns

UnternehmenPositionEnde
Vorstandsvorsitzender 01.10.2008
Direktor/Vorstandsmitglied -
Vorstandsvorsitzender -
Vorstandsvorsitzender -
Corporate Officer/Principal -
Sehen Sie sich die Erfahrung von Robert Burns im Detail an

Ausbildung von Robert Burns

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

23

Beziehungen ersten Grades

16

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen16

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Industrial Services

Health Technology

Technology Services

Consumer Services

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Börse
  2. Insiders
  3. Robert Burns
- 40 %: Die besten Tools - exklusiv für Abonnenten - um schon heute die Top-Anlagechancen von morgen zu erkennen!
T
:
:
PROFITIEREN SIE JETZT